Adherium Sets Up EU Base With Tarplee As Head
This article was originally published in Clinica
Developer of the SmartInhaler, Adherium Ltd, has established a European subsidiary which will be headed by John Tarplee, a veteran of the pharmaceutical industry with over 30 years’ experience. As Senior Vice-President Business development, Europe, Tarplee will lead market development and partnering activities in that region.
You may also be interested in...
SmartInhaler developer Adherium has appointed the co-founder of MicroDose Therapeutx to head up its European base in Amsterdam, Netherlands.
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.